REGIONAL ASSESSMENT OF SEVERE HYPOGLYCEMIC COMA EVENTS IN FINLAND

Author(s)

Vattulainen P1, Mushnikov V1, Hoti F1, Saukkonen T2, Korhonen P1
1EPID Research, Espoo, Finland, 2Novo Nordisk Farma, Espoo, Finland

OBJECTIVES: In a previous study about severe hypoglycemic coma events (SH) among diabetes mellitus (DM) patients we saw regional variation in SH occurrence. The purpose was to compare the incidence of SH between hospital districts in Finland. METHODS: This study among type 1 (T1) and 2 (T2) diabetic patients was based on nationwide health care registers. The study cohort contained insulin naïve diabetic patients who had filled at least one prescription of insulin during follow-up in 2006-2009. SH was defined as a hospitalization or a secondary health care visit due to hypoglycemic coma (ICD-10: E10.00 and E11.00). Stratified incidence rates and adjusted hazard ratio (HR) estimates with 95% confidence intervals (CI) were calculated. Analyses were performed for the first and recurrent SHs.  RESULTS: The population comprised 5271 (17.6%) patients with T1 and 24602 (82.4%) with T2. Altogether 3.1% patients experienced at least one SH during the follow-up. In different hospital districts the rate of first SHs varied from 5.6 (Varsinais-Suomi) to 47.8 (Länsi-Pohja) for T1, and from 4.8 (Pohjois-Karjala) to 50.3 (Länsi-Pohja) for T2. Compared to the capital area, the risks of first SHs varied differently for T1 and T2, but were commonly higher in Länsi-Pohja (T1: HR 3.46, CI 1.41-8.46; T2: HR 1.60, CI 1.13-2.29) and lower in Pohjois-Karjala (T1: no events; T2: HR 0.275, CI 0.14-0.56). Taking all SH events into account did not change these differences remarkably.  CONCLUSIONS: We found differences between regions in risk of hospital-treated SH in both DM types. Further analyses will be performed for e.g. ambulance density.

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PDB3

Topic

Epidemiology & Public Health

Topic Subcategory

Safety & Pharmacoepidemiology

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×